BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu W, Ma Z, Wang Y, Yang J. Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives. Bioactive Materials 2023;23:274-299. [DOI: 10.1016/j.bioactmat.2022.11.006] [Reference Citation Analysis]
2 Wadhwa G, Venkata Krishna K, Kumar Dubey S, Taliyan R. Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation. Int J Pharm 2023;636:122824. [PMID: 36921745 DOI: 10.1016/j.ijpharm.2023.122824] [Reference Citation Analysis]
3 Sanjanwala D, Patravale V. Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer. Drug Discov Today 2023;28:103550. [PMID: 36906220 DOI: 10.1016/j.drudis.2023.103550] [Reference Citation Analysis]
4 Wadhwa G, Krishna KV, Dubey SK, Taliyan R. PEGylated Polymer–Lipid Hybrid Nanoparticles to Enhance In Vivo Exposure and Uptake of Repaglinide in Brain Cells to Treat Diabetes-Linked Neurodegenerative Disorders. ACS Appl Nano Mater 2023. [DOI: 10.1021/acsanm.2c05272] [Reference Citation Analysis]
5 Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
6 Kumari S, Bhardwaj JS, Kharavtekar SS, Grewal D, Ray SG, Bhardwaj A, Dubey SK, Kesharwani P, Arora T, Taliyan R. Futuristic aspect of nanocarriers on targeted delivery for dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 2023. [DOI: 10.1016/b978-0-12-824331-2.00005-4] [Reference Citation Analysis]
7 Li L, He R, Yan H, Leng Z, Zhu S, Gu Z. Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 2022;47:101654. [DOI: 10.1016/j.nantod.2022.101654] [Reference Citation Analysis]
8 Hou T, Zhang N, Yan C, Ding M, Niu H, Guan P, Hu X. Curcumin-loaded protein imprinted mesoporous nanosphere for inhibiting amyloid aggregation. Int J Biol Macromol 2022;221:334-45. [PMID: 36084870 DOI: 10.1016/j.ijbiomac.2022.08.185] [Reference Citation Analysis]
9 Pardo-moreno T, González-acedo A, Rivas-domínguez A, García-morales V, García-cozar FJ, Ramos-rodríguez JJ, Melguizo-rodríguez L. Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 2022;14:1117. [DOI: 10.3390/pharmaceutics14061117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bukhari SNA. Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight. Antioxidants 2022;11:554. [DOI: 10.3390/antiox11030554] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]